Skip to main content
Year archive

Zur Rose Group AG — 2020 filings

All 32 regulatory filings released by Zur Rose Group AG (ROSE) in 2020, sourced directly from the official regulator.

32 Filings
2020 Period
2020 filings (32)
Filing Released Lang
Vor-Ort-Apotheken-Starkungsgesetz umgeht EuGH-Urteil
Legal Proceedings Report
2020-12-14 German
Local Pharmacy Strengthening Act circumvents ECJ ruling
Legal Proceedings Report
2020-12-14 English
Zur Rose Group AG: Olaf Heinrich, Head Germany, is leaving the Zur Rose Group; his successor will be Walter Hess, Head Switzerland
Board/Management Information
2020-12-10 English
Digitale Verschreibung von Gesundheits-Apps
Regulatory Filings
2020-12-07 German
Zur Rose Group: gematik awards tender for specialist e-prescription service - Zur Rose subsidiary eHealth-Tec involved as partner to IBM
Regulatory Filings
2020-11-16 English
Zur Rose Group accelerates growth in third quarter 2020
Earnings Release Q3 2020
2020-10-21 English
Zur Rose and KPT together launch digital medicines assistant Medi+
Regulatory Filings
2020-09-08 English
Zur Rose Group reinforces European market leadership by rigorously implementing the growth and platform strategy
Earnings Release H1 2020
2020-08-19 English
Presentation on the half-year results 2020
Investor Presentation
2020-08-19 English
Präsentation zum Halbjahresbericht 2020
Investor Presentation
2020-08-19 English
Halbjahresbericht 2020
Interim / Quarterly Report H2 2020
2020-08-19 German
Half-Year Report 2020
Interim / Quarterly Report H2 2020
2020-08-19 English
Zur Rose Group successfully concluded acquisition of the e-commerce and diabetes activities of Apotal Group
M&A Activity
2020-08-17 English
Zur Rose Group successfully concluded acquisition of TeleClinic
M&A Activity
2020-07-31 English
Zur Rose Group successfully completed capital increase from authorized capital and sets placement price
Capital/Financing Update
2020-07-17 English
Zur Rose Group AG resolves on capital increase from authorized Capital
Capital/Financing Update
2020-07-16 English
Zur Rose Group strengthens European market leadership through acquisition of mail-order and diabetes activities of Apotal Group
M&A Activity
2020-06-26 English
Zur Rose Group: Charges in connection with mail-order of non-prescription drugs and electronic prescribing
Legal Proceedings Report
2020-05-03 English
2020 Annual General Meeting of Zur Rose Group AG: Shareholders adopt all proposals
AGM Information
2020-04-23 English
Zur Rose Group starts 2020 with strong growth
Earnings Release Q1 2020
2020-04-16 English
Geschäftsbericht 2019
Annual Report FY 2019
2020-04-11 German
Annual Report 2019
Annual Report FY 2019
2020-04-11 English
Zur Rose Group AG publishes invitation to the Annual General Meeting on 23 April 2020
AGM Information
2020-04-02 English
Zur Rose Group AG successfully completes the placement of CHF 175 million Convertible Bonds due 2025
Capital/Financing Update
2020-03-26 English
Zur Rose Group AG launches CHF 150 million Convertible Bonds due 2025 with up to CHF 25 million increase option
Capital/Financing Update
2020-03-26 English
COVID-19: Zur Rose is calling for an exception allowing the mail-orders for over-the-counter emergency, cold and flu medicines
Regulatory Filings
2020-03-23 English
Zur Rose Group maintains growth momentum
Earnings Release FY 2019
2020-03-19 English
Presentation on the 2019 annual results
Investor Presentation
2020-03-19 English
Präsentation zum Jahresergebnis 2019
Investor Presentation
2020-03-19 English
Zur Rose Group broadens its leadership structure and completes Group Management
Board/Management Information
2020-03-12 English
Zur Rose Group posts 30 per cent growth in 2019
Earnings Release FY 2019
2020-01-22 English
Zur Rose Group strengthens Group Management: Bernd Gschaider becomes Chief Operations Officer
Board/Management Information
2020-01-13 English